Share This Article
Between June 2020 and March 2023, Four Seasons Health Care Group worked with University College London (UCL) researchers and the Department of Health and Social Care on a national research study called VIVALDI. The study investigated COVID-19 infections and the impact of the disease in care homes. The results of the study informed policy decisions around the best approach to testing and prevention of infections in care homes, helping to protect those living and working in care settings.
Four Seasons and brighterkind care homes in England have now partnered with the VIVALDI Social Care Study which builds on the learnings of the original study and aims to reduce infections in care homes.
Commissioned by The UK Health Security Agency (UKHSA) in collaboration with UCL, The Outstanding Society, Care England, and NHS England, this new study will monitor infections in care homes, including COVID-19, flu, norovirus, and urinary tract infections. VIVALDI’s mission is to improve the quality of life for people living, visiting, and working in care homes while reducing the risk of infections and avoiding hospital admissions.
Jacqui Ritchie, Chief Operating Officer, Four Seasons Health Care Group, said: “Following our partnership with VIVALDI during the pandemic, we are delighted to again be part of this important research study. Our help in this work to better understand infections in care homes is crucial to improve prevention and control, and the wellbeing of residents, their families and team members.”
Operating under the Four Seasons Health Care and brighterkind brands, Four Seasons Health Care Group has 50 care homes across the UK, caring for nearly 3,000 people. The group provides long-term and respite residential and nursing care for older people and are an award-winning, sector leader with an innovative approach to specialist dementia care.
Take a look at all of our awards and partnerships here.